Class summary at a glance.

Every drug in the Phenothiazine class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 9tracked in Part D
CY24 Part D spend: $179.5Mcombined across class
Total Rx claims: 4.2M1.7M unique beneficiaries
Generic mfrs (active): 98across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Chlorpromazine

Brand: ChlorproMAZINE Hydrochloride · 371K Part D claims (CY24) · 65K beneficiaries · First FDA approval: 1974-07-25

22 generic mfrs 361 plans require PA

Low NADAC$0.186

→

Avg plan cost$0.468

Part D spend $75.5M 3× spread, current vs floor

Class share

42%

of class CY24 spend

View profile →

Fluphenazine

Brand: Fluphenazine Hydrochoride · 327K Part D claims (CY24) · 46K beneficiaries · First FDA approval: 1988-08-25

22 generic mfrs 373 plans require PA Discontinued

Low NADAC$0.218

→

Avg plan cost$1.24

Part D spend $39.3M 6× spread, current vs floor

Class share

22%

of class CY24 spend

View profile →

Promethazine

Brand: PHENERGAN · 2.0M Part D claims (CY24) · 832K beneficiaries · First FDA approval: 1973-09-19

16 generic mfrs 912 plans require PA Active FDA shortage

Low NADAC$0.041

→

Avg plan cost$1.13

Part D spend $24.4M 27× spread, current vs floor

Class share

14%

of class CY24 spend

View profile →

Prochlorperazine

Brand: Compro · 1.2M Part D claims (CY24) · 686K beneficiaries · First FDA approval: 1989-08-29

21 generic mfrs 14 plans require PA

Low NADAC$0.121

→

Avg plan cost$0.809

Part D spend $18.2M 7× spread, current vs floor

Class share

10%

of class CY24 spend

View profile →

Perphenazine

287K Part D claims (CY24) · 42K beneficiaries · First FDA approval: 1988-12-08

9 generic mfrs 184 plans require PA

Low NADAC$0.178

→

Avg plan cost$0.237

Part D spend $16.7M 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Trifluoperazine

55K Part D claims (CY24) · 10K beneficiaries · First FDA approval: 1981-11-20

2 generic mfrs 180 plans require PA

Low NADAC$0.377

→

Avg plan cost$0.792

Part D spend $3.1M 2× spread, current vs floor

Class share

of class CY24 spend

View profile →

Thioridazine

38K Part D claims (CY24) · 6K beneficiaries · First FDA approval: 1983-03-15

1 generic mfrs 228 plans require PA

Low NADAC$0.445

→

Avg plan cost$0.631

Part D spend $2.2M 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Perphenazine and Amitriptyline

— Part D claims (CY24) · First FDA approval: 1988-11-10

1 generic mfrs 122 plans require PA

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Promethazine and Dextromethorphan Hydrobromide

Brand: Promethazine DM · — Part D claims (CY24) · First FDA approval: 1985-01-04

4 generic mfrs

Low NADAC$0.039

→

Avg plan cost$0.041

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.